newsfilter
← Latest News
Business Wire·

Summit Therapeutics Announces Proposed Public Offering of Common Stock

Summit Therapeutics Inc. (NASDAQ:SMMT) ("Summit," "we," or the "Company") today announced that it has commenced an underwritten public offering of $500.0 million of shares of its common stock. All of the shares in the